Log in or Sign up for Free to view tailored content for your specialty!
Liver/Biliary Disorders News
Obeticholic acid yields fewer deaths, liver transplants in primary biliary cholangitis
Patients who received obeticholic acid for primary biliary cholangitis experienced greater transplant-free survival compared with external control patients, according to research published in Gastroenterology.
Non-liver-related mortality can be higher in NAFLD ‘depending on age, fibrosis stage’
A patient outcomes simulator found that non-liver-related mortality could surpass liver-related mortality in patients with nonalcoholic fatty liver disease, depending on age and fibrosis stage at diagnosis, noted data in JAMA Network Open.
Log in or Sign up for Free to view tailored content for your specialty!
HIV, hepatitis C coinfection drives MI risk with increasing age
People with HIV and untreated hepatitis C virus have an 85% higher risk for type 1 MI per each 10-year increase in age, researchers reported.
Risk for liver cancer rises with each generation among US residents of Mexican descent
Second- and third-generation individuals of Mexican descent who reside in the U.S. had a higher risk for developing hepatocellular carcinoma than first-generation U.S. Mexicans, according to study results.
Fewer deaths from alcohol-related disease in areas with higher-density gastroenterologists
Higher state-level geographic density of gastroenterologists was linked with decreased mortality from alcohol-associated liver disease in adults aged 25 years or older, according to new data in Clinical Gastroenterology and Hepatology.
Exposure to widespread synthetic pollutants linked to surprising ‘magnitude’ of HCC risk
Investigators have identified an elevated risk for hepatocellular carcinoma in people exposed to per- and polyfluoroalkyl substances, according to a study published in JHEP Reports.
FDA approves Xenpozyme, first treatment for rare acid sphingomyelinase deficiency
The FDA has approved Xenpozyme as the first treatment for patients with acid sphingomyelinase deficiency with symptoms unrelated to the central nervous system.
Fazirsiran ‘quite amazing’ in treatment of alpha-1 antitrypsin deficiency liver disease
Fazirsiran effectively reduced the production and accumulation of a protein that causes alpha-1 antitrypsin deficiency and subsequent liver fibrosis in a small subset of patients, according to data in The New England Journal of Medicine.
Liver transplantation ‘remains the standard of care’ for HCC patients, regardless of age
Despite increased perioperative risks in older patients with hepatocellular carcinoma and cirrhosis, orthotropic liver transplantation provides greater survival benefit compared with ablative therapies, according to new research.
Evening chronotype associated with more severe NAFLD for adults with obesity
Evening chronotype was associated with more severe nonalcoholic fatty liver disease independent of age, sex and BMI compared with morning chronotype among adults with obesity, according to data published in International Journal of Obesity.
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read